Ozempic

Novo Nordisk Faces Revenue Decline Amid Price Cuts and Patent Challenges

Novo Nordisk's Semaglutide Fails to Slow Alzheimer's Progression, Shares Plummet

Eli Lilly's Mounjaro Faces Price Hike and Shipment Pause in the UK

Serena Williams's Weight Loss Journey: A New Chapter in the Anti-Obesity Drug Debate

Novo Nordisk Faces Challenges Amidst Rising Competition in Weight-Loss Drug Market

Study Launched to Probe Pancreatitis Risks in Weight Loss Jab Users